vimarsana.com

Page 3 - ப்ரொ மருந்து வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pro Medicus (ASX:PME) share price sinks despite new deal

Pro Medicus (ASX:PME) share price sinks despite new deal Aaron Teboneras | May 13, 2021 10:42am | More on: The Pro Medicus Limited(ASX: PME) share price is a poor performer so far on Thursday despite the company providing a positive update. In early morning trade, the health imaging company’s shares are fetching $40.05, down 1.26%. What was announced? Investors have been selling Pro Medicus shares regardless of the company’s announced contract win. According to its release, Pro Medicus’ wholly-owned United Stated subsidiary, Visage Imaging Inc., has signed a deal with The University of Vermont Health Network Inc (UVM). Under the agreement, Pro Medicus will deploy its Visage 7 Enterprise Imaging Platform across 6 hospitals operated by UVM. It is expected that, once the system is fully functional, a unified diagnostic imaging platform will run across the network. This replaces the existing multiple legacy PACS platforms that are currently being used.

ASX 200 up 0 45%: Macquarie full year results & REA Group Q3 update

ASX 200 up 0.45%: Macquarie full year results & REA Group Q3 update ASX 200 up 0.45%: Macquarie full year results & REA Group Q3 update Macquarie Group Ltd (ASX:MQG) and REA Group Limited (ASX:REA) shares are making a splash on the ASX 200 on Friday… James Mickleboro has been a Motley Fool contributor since late 2015. After studying economics at university back home in the United Kingdom, James came to live in Australia and managed to land a job at an Australian fund manager. This was the start of a love affair with Australian equities and he hasn t looked back since. James is part of the CFA Institute s Chartered Financial Analyst program and hopes it teaches him how to become an astute investor which allows him to help others with their own investing. Outside of reading and researching he spends many a late night watching the English Premier League and Seinfeld reruns.

Why the Pro Medicus (ASX:PME) share price is climbing today

Why the Pro Medicus (ASX:PME) share price is climbing today Aaron Teboneras | February 19, 2021 10:49am | More on: Image source: Getty Images Pro Medicus Limited(ASX: PME) shares are climbing in morning trade despite the company announcing its co-founders have offloaded a parcel of their shares. At the time of writing, the Pro Medicus share price is up 2.5% to $46.40. Co-founders sell shares The Pro Medicus share price is on the rise regardless of the fact the health imaging company reported its co-founders have sold off a portion of their stake in the business. According to this morning’s release, Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall have each sold 1 million shares. The sale transacted at market close yesterday (18 February) at the price of $45.97 per share.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.